Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-25-228341

Chief Financial Officer sold 10,558 shares at $14.65 ($154,650)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FRATES JAMES M Chief Financial Officer 2025-09-30 Sale −10,558 $14.65 $154,650 280,430 D
Open-market sales · 10,558 sh · avg $14.65 · $154,650
Loading xslF345X05/ownership.xml…